Sunekos Cell 15 is an injectable cellulite treatment by Sunekos, developed around the extracellular matrix rather than the fat cell. It is suitable for qualified practitioners treating cellulite, framed as Edematous Fibrosclerotic Panniculopathy, across stages I to IV. The product relies on a synergy of hyaluronic acid, amino acids and an alkaline solution in a non-lipoclastic, non-lipolytic approach and is intended for professional use.
主要优势: Sunekos Cell 15
- CE-marked Class III medical device
- Promotes optimisation of extracellular matrix protein turnover
- Supports neo-collagenesis rather than collagenase
- Helps improve microcirculation
- Helps reduce fibrosis by re-equilibrating extracellular matrix inflammation
- Helps regulate physiological pH
- Non-invasive, non-lipoclastic and non-lipolytic approach focused on restructuring the extracellular matrix
- Supported by a preliminary study on 25 subjects reporting a reduction in clinical evaluation score in both cellulite stage groups
适应症与专业用途
主要适应症
- Cellulite, framed as Edematous Fibrosclerotic Panniculopathy (EFP)
- Cellulite stages I and II
- Cellulite stages III and IV
- Fibrosis and extracellular matrix inflammation associated with cellulite
- Impaired microcirculation associated with cellulite
专业用途
Sunekos Cell 15 is a CE-marked Class III medical device intended for medical-practitioner use only. It is supplied as a two-component treatment pack that is reconstituted before use, combining low-molecular-weight sodium hyaluronate and amino acids with carbonate/bicarbonate salts.
治疗部位
- Cellulite-affected areas of the thighs and gluteal/trochanteric region
适用患者
Sunekos Cell 15 is intended for adult patients presenting with cellulite / Edematous Fibrosclerotic Panniculopathy (EFP), including stages I–IV. A preliminary clinical evaluation included 25 subjects, with 11 in stages I–II and 14 in stages III–IV.
作用原理: Sunekos Cell 15
Sunekos Cell 15 works through a synergy of hyaluronic acid, amino acids and an alkaline solution. Where earlier intradermal approaches to cellulite mainly addressed edema and microcirculation, this combination also targets the extracellular matrix: it is designed to optimise extracellular matrix protein turnover, improve microcirculation, reduce fibrosis by re-equilibrating matrix inflammation and help regulate physiological pH. The approach is non-lipoclastic and non-lipolytic, rebuilding rather than destroying, which makes it suitable for restoring skin and adipose tissue homeostasis rather than breaking down fat.
为什么选择在 Allpara 订购
Allpara 提供正品、经过验证的 SUNEKOS 产品,来自经过严格审核的供应商,具备完整的批次可追溯性和专家支持。我们为诊所和医美专业人士提供CE认证产品、从欧盟仓库快速配送至欧盟各地,以及具有竞争力的专业价格。我们关注的是您患者的安全、满意度和效果,并提供专属售后支持,让您安心无忧。
常见问题
Which cellulite stages does Sunekos Cell 15 treat?
Sunekos Cell 15 shows indications for cellulite stages I and II and for stages III and IV, with staging determined by the treating practitioner before treatment.
How does Sunekos Cell 15 differ from lipolytic cellulite treatments?
Sunekos Cell 15 is a non-lipoclastic and non-lipolytic approach. Instead of breaking down fat, it restructures the extracellular matrix, an approach of rebuilding rather than destroying.
Why does Sunekos Cell 15 include an alkaline solution?
The alkaline solution is part of the synergy that helps regulate physiological pH and re-equilibrate extracellular matrix inflammation, which helps reduce the fibrosis component of cellulite.
更多产品: Professional Dietetics
诊所替代选择
继续浏览
Sunekos Cell 15 is an injectable cellulite treatment by Sunekos, developed around the extracellular matrix rather than the fat cell. It is suitable for qualified practitioners treating cellulite, framed as Edematous Fibrosclerotic Panniculopathy, across stages I to IV. The product relies on a synergy of hyaluronic acid, amino acids and an alkaline solution in a non-lipoclastic, non-lipolytic approach and is intended for professional use.
主要优势: Sunekos Cell 15
- CE-marked Class III medical device
- Promotes optimisation of extracellular matrix protein turnover
- Supports neo-collagenesis rather than collagenase
- Helps improve microcirculation
- Helps reduce fibrosis by re-equilibrating extracellular matrix inflammation
- Helps regulate physiological pH
- Non-invasive, non-lipoclastic and non-lipolytic approach focused on restructuring the extracellular matrix
- Supported by a preliminary study on 25 subjects reporting a reduction in clinical evaluation score in both cellulite stage groups
适应症与专业用途
主要适应症
- Cellulite, framed as Edematous Fibrosclerotic Panniculopathy (EFP)
- Cellulite stages I and II
- Cellulite stages III and IV
- Fibrosis and extracellular matrix inflammation associated with cellulite
- Impaired microcirculation associated with cellulite
专业用途
Sunekos Cell 15 is a CE-marked Class III medical device intended for medical-practitioner use only. It is supplied as a two-component treatment pack that is reconstituted before use, combining low-molecular-weight sodium hyaluronate and amino acids with carbonate/bicarbonate salts.
治疗部位
- Cellulite-affected areas of the thighs and gluteal/trochanteric region
适用患者
Sunekos Cell 15 is intended for adult patients presenting with cellulite / Edematous Fibrosclerotic Panniculopathy (EFP), including stages I–IV. A preliminary clinical evaluation included 25 subjects, with 11 in stages I–II and 14 in stages III–IV.
作用原理: Sunekos Cell 15
Sunekos Cell 15 works through a synergy of hyaluronic acid, amino acids and an alkaline solution. Where earlier intradermal approaches to cellulite mainly addressed edema and microcirculation, this combination also targets the extracellular matrix: it is designed to optimise extracellular matrix protein turnover, improve microcirculation, reduce fibrosis by re-equilibrating matrix inflammation and help regulate physiological pH. The approach is non-lipoclastic and non-lipolytic, rebuilding rather than destroying, which makes it suitable for restoring skin and adipose tissue homeostasis rather than breaking down fat.
为什么选择在 Allpara 订购
Allpara 提供正品、经过验证的 SUNEKOS 产品,具备完整的批次可追溯性、CE认证库存、欧盟范围内快速配送以及专业的售后支持。
常见问题
Which cellulite stages does Sunekos Cell 15 treat?
Sunekos Cell 15 shows indications for cellulite stages I and II and for stages III and IV, with staging determined by the treating practitioner before treatment.
How does Sunekos Cell 15 differ from lipolytic cellulite treatments?
Sunekos Cell 15 is a non-lipoclastic and non-lipolytic approach. Instead of breaking down fat, it restructures the extracellular matrix, an approach of rebuilding rather than destroying.
Why does Sunekos Cell 15 include an alkaline solution?
The alkaline solution is part of the synergy that helps regulate physiological pH and re-equilibrate extracellular matrix inflammation, which helps reduce the fibrosis component of cellulite.